Fenchem Enterprises Ltd.

March 28, 2008

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal

CHINO, Calif.—Targeting the U.S. mood product market, Fenchem (Fenchem.com) will launch a new product,  SAMe-way™. According to the company, SAM-e (S-adenosyl-methionine) is a prescription medication in European countries used to treat depression and joint pain, but is sold as a supplement in the United States, where annual sales were close to $100 million in 2007. SAM-way is available in two forms of Ademetionine 1,4-butanedisulfonate and Ademetionine disulfate tosylate

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like